Cholesterol

( DrugBank: Cholesterol / KEGG DRUG: Cholesterol )


5 diseases
IDDisease name (Link within this page)Number of trials
19Lysosomal storage disease26
90Retinitis pigmentosa1
160Congenital ichthyosis3
IDDisease name (Link within this page)Number of trials
222Primary nephrotic syndrome2
310Congenital anomalies syndrome7

19. Lysosomal storage disease


Clinical trials : 990Drugs : 584 - (DrugBank : 126) / Drug target genes : 62 - Drug target pathways : 192 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

90. Retinitis pigmentosa


Clinical trials : 186Drugs : 191 - (DrugBank : 52) / Drug target genes : 43 - Drug target pathways : 87 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

160. Congenital ichthyosis


Clinical trials : 57Drugs : 68 - (DrugBank : 25) / Drug target genes : 21 - Drug target pathways : 141 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

222. Primary nephrotic syndrome


Clinical trials : 382Drugs : 278 - (DrugBank : 98) / Drug target genes : 73 - Drug target pathways : 197 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

310. Congenital anomalies syndrome


Clinical trials : 12Drugs : 16 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 8 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries